The Food and Drug Administration (FDA) has approved the use of Sinovac vaccines for senior citizens.
FDA director general Eric Domingo said The China-made vaccine was approved yesterday, upon recommendation of the Vaccine Expert Panel (VEP).
“After considering the recommendation of the experts and the current situation of high COVID-19 transmission and limited available vaccine, the FDA is allowing the use of Sinovac on senior citizens,” Domingo said.
Domingo said however that vaccination “should be preceded by an evaluation of the person’s health status and exposure risk to assure that benefits of vaccination outweigh the risk.”
“Its safety profile is good, the signs and symptoms are mild to moderate based on the studies done in Brazil, although the senior citizens that participated in the trial were few, around 400,” VEP head Nina Gloriani said at a public briefing.
She said the VEP studied the “safety profile” of Sinovac when used on those aged 60 and above.
April 7, 2021
MANILA – The country’s vaccine expert panel (VEP) has recommended the administration of the CoronaVac vaccine manufactured by China’s Sinovac Biotech to individuals aged 60 and above, Malacañang announced Wednesday.“We confirm that the Vaccine Expert Panel has… Read More